Xilio Therapeutics, Inc. SEC filings XLO
Xilio Therapeutics, Inc. has 357 filings in SEC EDGAR's recent list, going back to Jan 21, 2021. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 12, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Aug 12, 2026 | Aug 12, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 12, 2026 | Jun 10, 2026 |
| 8-K |
Current report
Results of operations
|
May 12, 2026 | May 12, 2026 |
| 8-K |
Current report
Officer or director change
|
Apr 16, 2026 | Apr 15, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 23, 2026 | Mar 23, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Mar 12, 2026 | Mar 12, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 9, 2026 | Mar 9, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Feb 24, 2026 | Feb 23, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Feb 12, 2026 | Feb 11, 2026 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Jan 8, 2026 | Jan 6, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 5, 2026 | Jan 5, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Nov 25, 2025 | Nov 21, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2025 | Nov 13, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 7, 2025 | Nov 7, 2025 |
| 8-K |
Current report
Listing notice
|
Oct 3, 2025 | Oct 2, 2025 |
| 8-K |
Current report
Other events
|
Sep 9, 2025 | Sep 9, 2025 |
| 8-K |
Current report
Listing notice
|
Aug 28, 2025 | Aug 22, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2025 | Aug 14, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 12, 2025 | Jun 10, 2025 |
| 8-K |
Current report
Officer or director change
|
Jun 10, 2025 | Jun 10, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Jun 3, 2025 | Jun 2, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 2, 2025 | May 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| 8-K |
Current report
Listing notice
|
Apr 8, 2025 | Apr 4, 2025 |
| 8-K |
Current report
Material agreement
|
Mar 11, 2025 | Mar 11, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 11, 2025 | Mar 11, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Feb 12, 2025 | Feb 10, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 21, 2025 | Jan 21, 2025 |
| 8-K |
Current report
Unregistered share sale, Regulation FD disclosure, Other events
|
Dec 19, 2024 | Dec 18, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Nov 7, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Listing notice
|
Sep 13, 2024 | Sep 10, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 17, 2024 | Jun 13, 2024 |
| 8-K |
Current report
Officer or director change
|
Jun 13, 2024 | Jun 13, 2024 |
| 8-K |
Current report
Results of operations
|
May 14, 2024 | May 14, 2024 |
| 8-K |
Current report
Results of operations
|
Apr 1, 2024 | Apr 1, 2024 |
| 8-K |
Current report
Other events
|
Mar 28, 2024 | Mar 28, 2024 |
| 8-K |
Current report
Material agreement, Results of operations, Exit or restructuring costs, Unregistered share sale, Regulation FD disclosure, Other events
|
Mar 28, 2024 | Mar 27, 2024 |
| 8-K |
Current report
Listing notice
|
Jan 19, 2024 | Jan 19, 2024 |
| 8-K |
Current report
Officer or director change
|
Jan 3, 2024 | Jan 1, 2024 |
| 8-K |
Current report
Other events
|
Dec 7, 2023 | Dec 7, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2023 | Nov 9, 2023 |
| 8-K |
Current report
Other events
|
Nov 3, 2023 | Nov 3, 2023 |
| 8-K |
Current report
Officer or director change, Other events
|
Sep 5, 2023 | Aug 30, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 14, 2023 | Aug 14, 2023 |
| 8-K |
Current report
Officer or director change
|
Aug 3, 2023 | Aug 3, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2023 | Jun 8, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 25, 2023 | May 25, 2023 |
| 8-K |
Current report
Results of operations
|
May 9, 2023 | May 9, 2023 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change
|
Apr 3, 2023 | Mar 28, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 2, 2023 | Mar 2, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 9, 2023 | Jan 9, 2023 |
| 8-K |
Current report
Officer or director change
|
Dec 23, 2022 | Dec 19, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 9, 2022 | Nov 9, 2022 |
| 8-K |
Current report
Officer or director change
|
Sep 15, 2022 | Sep 15, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2022 | Aug 9, 2022 |
| 8-K |
Current report
Officer or director change
|
Jul 28, 2022 | Jul 25, 2022 |
| 8-K |
Current report
Officer or director change
|
Jun 16, 2022 | Jun 15, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2022 | Jun 9, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 12, 2022 | May 12, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 1, 2022 | Mar 1, 2022 |
| 8-K |
Current report
Officer or director change
|
Feb 4, 2022 | Feb 3, 2022 |
| 8-K |
Current report
Officer or director change
|
Jan 6, 2022 | Jan 4, 2022 |
| 8-K |
Current report
Results of operations
|
Dec 2, 2021 | Dec 2, 2021 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Oct 26, 2021 | Oct 26, 2021 |
Showing 65 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- XLO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Waltham, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1840233
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.